2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS
This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-² (TGF-²) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English Serbian |
Published |
30.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-² (TGF-²) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors. |
---|---|
AbstractList | This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-² (TGF-²) type I receptor (ALK5) and/or the activin type I receptor (ALK4), methods for their preparation, and their use in medicine, specifically in the treatment and prevention of a disease state mediated by these receptors. |
Author | JIN, CHENG, HUA KIM, DAE, KEE SUBRAHMANYAM, VURA, BALA SREENU, DOMALAPALLY RAO, KOTA, SUDHAKAR PARK, CHUL-YONG SHEEN, YHUN, YHONG KRISHNAIAH, MADDEBOINA |
Author_xml | – fullname: SHEEN, YHUN, YHONG – fullname: PARK, CHUL-YONG – fullname: KIM, DAE, KEE – fullname: SREENU, DOMALAPALLY – fullname: SUBRAHMANYAM, VURA, BALA – fullname: RAO, KOTA, SUDHAKAR – fullname: JIN, CHENG, HUA – fullname: KRISHNAIAH, MADDEBOINA |
BookMark | eNrjYmDJy89L5WTwNtINiAzydIn0UQgOdQoO8QwJDXF1UfD09XRxjPL3cQ1WcAxWCPFwDXIMcA0N8XRWcPTxNlVw9HPR9w8CsU0UPP08PJ08Q_yDgnkYWNMSc4pTeaE0N4Ocm2uIs4duakF-fGpxQWJyal5qSXxQsKmZuaGBk6ExQQUAppUuQg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | 2-PIRIDIL SUPSTITUISANI IMIDAZOLI KAO TERAPEUTSKI INHIBITORI ALK5 I/ILI ALK4 |
ExternalDocumentID | RS56710B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_RS56710B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:11:25 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Serbian |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_RS56710B13 |
Notes | Application Number: RS2017P001245 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180330&DB=EPODOC&CC=RS&NR=56710B1 |
ParticipantIDs | epo_espacenet_RS56710B1 |
PublicationCentury | 2000 |
PublicationDate | 20180330 |
PublicationDateYYYYMMDD | 2018-03-30 |
PublicationDate_xml | – month: 03 year: 2018 text: 20180330 day: 30 |
PublicationDecade | 2010 |
PublicationYear | 2018 |
RelatedCompanies | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION |
RelatedCompanies_xml | – name: EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION |
Score | 3.1336877 |
Snippet | This invention relates to 2-pyridyl substituted imidazoles (I) which are inhibitors of the transforming growth factor-² (TGF-²) type I receptor (ALK5) and/or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 AND/OR ALK4 INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180330&DB=EPODOC&locale=&CC=RS&NR=56710B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb8IwDI4Qm7bdNvZgL5TD1FtFWR_QQzW1TVE7oK2SdoJdEJRk2gUQdNrfn4nKtgs3K5Esx5IfXxLbCD3NOrbgkEaoJuQeqsHFQrW5LlRdKzqmsMXCkpPnRrEV5sbr2BzX0Me-Fkb2Cf2WzRHBogqw91L66_XfJRaRfyu37fknLK1e-plDlAodd3oa4HOFeE6QJiTxFd93KFNi6pgWhFIPYNIR5NBdidjevF1Jyvp_POmfo-MUWC3LC1Tbbhro1N-PXWugk1H12g1kZXjbSzR4VtMJjchkiFnusSzKcnA5GDwPcd-TYcCwy3AWBtRNgzyLfOwOByZ2Y9JO6I42cBSHkRdlCWVXqNUPMj9UQarp7_mnlFXS69eovlwteRNhk2td0dVmfA4JjW707GJWAJITAKesBTi_W3RzgMndwZ17dLZToay40x5Qvdx88UcIueW8JdX1A6ybf_k |
link.rule.ids | 230,309,783,888,25577,76883 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8JAEJ4QNOJN8YEv3IPpraHYB_TQmL5IK6VtulsDXgiU1ngBAjX-fYdNUS_cJrvJZHaSeXy7OzMAT7OuXuSYRogq5h6ikhcLUc_lQpSlrKsWerHQ-OS5Uah5qfI6Vsc1-NjXwvA-od-8OSJaVIb2XnJ_vf67xHL438ptZ_6JS6uXATMcoULH3b6E-FxwLMONIyeyBds2EiqEiaFqGEothElHmF_3OU56s3YlKev_8WRwBscxslqW51DbbprQsPdj15pwMqpeu5GsDG97AcNnMZ4kvjMJCE0tynyWossh6Hkc8z0KXEpMSpjnJmbspsy3iRkMVWKGTidKdrRC_NDzLZ9FCb2E9sBltieiVNPf808TWkkvX0F9uVrmLSBqLvWKnjTL55jQyEpfz2YZIrkC4ZS2QOd3A9cHmNwe3HmEhsdGwTTww-EdnO7UyavvpHuol5uv_AHDbzlvc9X9ANUFguk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-PYRIDYL+SUBSTITUTED+IMIDAZOLES+AS+THERAPEUTIC+ALK5+AND%2FOR+ALK4+INHIBITORS&rft.inventor=SHEEN%2C+YHUN%2C+YHONG&rft.inventor=PARK%2C+CHUL-YONG&rft.inventor=KIM%2C+DAE%2C+KEE&rft.inventor=SREENU%2C+DOMALAPALLY&rft.inventor=SUBRAHMANYAM%2C+VURA%2C+BALA&rft.inventor=RAO%2C+KOTA%2C+SUDHAKAR&rft.inventor=JIN%2C+CHENG%2C+HUA&rft.inventor=KRISHNAIAH%2C+MADDEBOINA&rft.date=2018-03-30&rft.externalDBID=B1&rft.externalDocID=RS56710B1 |